Acute myeloid leukaemia (AML) treatment focuses on removing cancerous cells from the bone marrow and restoring normal blood cell production. It usually combines chemotherapy, targeted therapy, stem cell transplant, and, in some cases, radiation therapy.
AML is a blood and bone marrow cancer that develops from immature white blood cells (called myeloblasts). These abnormal cells grow quickly, crowding out healthy blood cells and leading to symptoms such as anaemia, infections, and bleeding problems.
A common misconception is that AML only affects older adults. While it is more common in people over 60, it can also occur in children and young adults.
The main types of AML include:
Doctors design a treatment plan based on:
The goal of treatment is to achieve remission, restore healthy blood counts, and prevent relapse. Early diagnosis and advanced care greatly improve survival chances.
AML treatment is necessary because the disease progresses rapidly and can be life-threatening if left untreated. Proper care helps control abnormal blood cell growth, reduce infection risks, and improve survival.
The exact cause is not always known, but several factors increase the risk:
AML symptoms are often mistaken for common illnesses. Warning signs include:
Doctors recommend starting AML treatment when:
Early diagnosis and timely treatment greatly improve the chances of remission. Patients can connect with myheco for guidance on the leading hospitals and treatment plans.
Some of the world’s most advanced cancer hospitals offer specialised care for patients with Acute Myeloid Leukaemia (AML) and other blood cancers. These centres provide comprehensive haematology services, including chemotherapy, targeted therapy, supportive care, and stem cell transplantation where clinically appropriate. Treatment is typically delivered by experienced haematologists working within multidisciplinary oncology teams.
Leading hospitals for Acute Myeloid Leukaemia (AML) care include:
.jpg)
.png)
.png)
.png)
.png)
.png)
These hospitals provide evidence-based treatment protocols, stem cell transplant expertise, and coordinated care for international patients seeking treatment for Acute Myeloid Leukaemia (AML).
The typical cost of Acute Myeloid Leukaemia (AML) treatment usually ranges between $10,000 and $40,000 in India and from $20,000 to $120,000 in Thailand. However, the overall cost can vary depending on the treatment plan, hospital, and the patient’s condition. Before reviewing the detailed cost breakdown, it is important to understand the key factors that influence these expenses.
Success rates for AML treatment vary depending on the patient’s age, subtype of AML, and whether a stem cell transplant is performed.
Success in AML treatment does not always mean a cure. It may include:
Renowned cancer hospitals adopt a comprehensive approach to AML treatment, including:
This blend of modern technology, experienced specialists, and patient-centred care has improved remission rates and survival outcomes for AML patients worldwide.
Dr. Padmaja Lokireddy from Apollo Cancer Centre, Hyderabad, explains that acute leukaemias like AML progress quickly and need urgent treatment. She notes that stem cell transplant can provide long-term remission, with many patients achieving survival beyond five years. She also highlights that new options like CAR-T therapy are emerging for high-risk cases.
Myheco ensures that international patients receive complete support, from connecting with experienced haematology and oncology specialists to managing every aspect of their treatment journey. With transparent guidance, expert coordination, and trusted hospital partnerships, myheco helps patients access advanced AML treatment safely and efficiently.
Choosing myheco means expert care, faster access, and comprehensive support throughout your treatment journey.
Note: Myheco does not provide medical advice.
A 30-year-old man from Somalia arrived at Apollo Cancer Hospital, Hyderabad, with severe weight loss and very high white blood cell counts. He was diagnosed with acute myeloid leukaemia (AML) carrying the high-risk FLT3D mutation. Initial chemotherapy reduced his cancer but did not achieve remission. A second-line FLAG regimen was successful, followed by an allogeneic sibling stem cell transplant. Three months later, he is in full remission with 100% donor chimerism and is preparing to return home.
Mr. Sheshagiri Rao, a 70-year-old advocate from Kovvuru, was diagnosed with acute myeloid leukaemia (AML) at an advanced stage after months of severe leg pain and sleeplessness. Under the care of Dr. Padmaja Lokireddy at Apollo Hospitals, Hyderabad, he received a gentle chemotherapy plan tailored to his age and health conditions. Over two years, he gradually regained strength and is now living a healthy life. His wife expressed deep gratitude for the compassionate care, while Dr. Lokireddy highlighted that age is not a barrier to AML treatment.
✅ Share your medical reports
✅ Receive personalised treatment plans from leading hospitals
✅ Choose the option that suits you best
✅ Let us handle the arrangements
AML symptoms include fatigue, frequent infections, unexplained bleeding, bone pain, and weight loss. A blood test and bone marrow biopsy confirm the diagnosis.
AML is managed by haematologists, oncologists, and bone marrow transplant specialists working as a team.
Treatment may last several months, including chemotherapy cycles, targeted therapy, or transplant recovery. Follow-up is required for years.
Success depends on age and subtype. Younger patients may have a 40-50% five-year survival rate, while older patients may have lower outcomes.
Yes, most hospitals allow one or two family members. A medical attendant visa can be arranged.
Not always. Some patients achieve remission with chemotherapy and targeted drugs, but a transplant is advised for high-risk cases.
We assist with doctor consultations, cost estimates, visas, travel, and follow-up care, ensuring international patients receive complete support.
India has several leading hospitals that specialise in acute myeloid leukaemia (AML) treatment. In Chennai, leading centres include SIMS Hospital, MGM Healthcare, Apollo Cancer Institute, and the Apollo Proton Cancer Centre. Bangalore’s Manipal Hospital Main Hospital Oncology is recognised for advanced haematology and transplant services. In Delhi, Manipal Hospital Dwarka, Max Hospital Saket, and BLK-Max Hospital are leading providers. Mumbai’s Nanavati Max Hospital and Kolkata’s Manipal Hospitals EM Bypass (Medica Synergie Cancer Hospital) are also well regarded for comprehensive AML care.
Samitivej Hospital is a leading choice for AML treatment in Thailand. It provides advanced diagnostics, chemotherapy, targeted therapy, stem cell transplant facilities, and international patient support through a dedicated haematology team.
DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE
The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material or content on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website - www.myheco.com
.png)